Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2011

01-12-2011 | Review Article

Friedreich’s Ataxia: a review from a cardiology perspective

Authors: T. Bourke, D. Keane

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2011

Login to get access

Abstract

Background

Neuromuscular disorders are not among the common causes of cardiomyopathy in the general population; however, cardiomyopathy is known to occur in several neuromuscular disorders including Friedreich’s Ataxia (FA). In patients with neuromuscular disorders, concomitant cardiac involvement contributes significantly to morbidity and mortality and often leads to premature death.

Methods

An extensive literature search of Medline and Pubmed was conducted to include all published reports on cardiac involvement in FA. Secondary articles were identified from key paper reference listings.

Conclusion

Hypertrophic cardiomyopathy is a cardinal feature of FA; therefore all FA patients should be screened for cardiomyopathy. A cardiac examination, ECG and ECHO are advised at diagnosis, and also on the development of any cardiac symptoms. Treatment is determined by the presence of symptoms, the presence of left ventricular outflow gradient and the sudden death risk. Institution of aggressive medical therapy early in the course of the disease may help improve quality of life and provide survival benefit.
Literature
1.
go back to reference Chamberlain S, Shaw J, Rowland A et al (1988) Mapping of mutation causing Friedreich’s ataxia to human chromosome 9. Nature 334(6179):248–250PubMedCrossRef Chamberlain S, Shaw J, Rowland A et al (1988) Mapping of mutation causing Friedreich’s ataxia to human chromosome 9. Nature 334(6179):248–250PubMedCrossRef
2.
go back to reference Delatycki MB, Williamson R, SM Forrest (2000) Friedreich ataxia: an overview. J Med Genet 37(1):1–8 Delatycki MB, Williamson R, SM Forrest (2000) Friedreich ataxia: an overview. J Med Genet 37(1):1–8
3.
go back to reference Child JS, Perloff JK, Bach PM, Wolfe AD, Perlman S, Kark RA (1986) Cardiac involvement in Friedreich’s ataxia: a clinical study of 75 patients. J Am Coll Cardiol 7(6):1370–1378PubMedCrossRef Child JS, Perloff JK, Bach PM, Wolfe AD, Perlman S, Kark RA (1986) Cardiac involvement in Friedreich’s ataxia: a clinical study of 75 patients. J Am Coll Cardiol 7(6):1370–1378PubMedCrossRef
4.
go back to reference Lewis WR, Yadlapalli S (1998) Management of cardiac complications in neuromuscular disease. Phys Med Rehabil Clin N Am 9(1):145–66, vii Lewis WR, Yadlapalli S (1998) Management of cardiac complications in neuromuscular disease. Phys Med Rehabil Clin N Am 9(1):145–66, vii
5.
go back to reference Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104(3):589–620PubMedCrossRef Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104(3):589–620PubMedCrossRef
6.
go back to reference De Michele GPF (1996) Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich’s disease: a retrospective study on 119 patients. Neurology 47:1260–1264PubMed De Michele GPF (1996) Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich’s disease: a retrospective study on 119 patients. Neurology 47:1260–1264PubMed
7.
go back to reference Filla A, DeMichele G, Caruso G, Marconi R, Campanella G (1990) Genetic data and natural history of Friedreich’s disease: a study of 80 Italian patients. J Neurol 237(6):345–351PubMedCrossRef Filla A, DeMichele G, Caruso G, Marconi R, Campanella G (1990) Genetic data and natural history of Friedreich’s disease: a study of 80 Italian patients. J Neurol 237(6):345–351PubMedCrossRef
8.
go back to reference Casazza F, Ferrari F, Piccone U, Maggiolini S, Capozi A, Morpurgo M (1990) Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study. Cardiologia 35(5):423–431PubMed Casazza F, Ferrari F, Piccone U, Maggiolini S, Capozi A, Morpurgo M (1990) Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study. Cardiologia 35(5):423–431PubMed
9.
go back to reference Casazza F, Morpurgo M (1996) The varying evolution of Friedreich’s ataxia cardiomyopathy. Am J Cardiol 77(10):895–898PubMedCrossRef Casazza F, Morpurgo M (1996) The varying evolution of Friedreich’s ataxia cardiomyopathy. Am J Cardiol 77(10):895–898PubMedCrossRef
10.
go back to reference Durr A, Cossee M, Agid Y et al (1996) Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 335(16):1169–1175PubMedCrossRef Durr A, Cossee M, Agid Y et al (1996) Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 335(16):1169–1175PubMedCrossRef
11.
go back to reference Bit-Avragim N, Perrot A, Schols L et al (2001) The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich’s ataxia. J Mol Med 78(11):626–632PubMedCrossRef Bit-Avragim N, Perrot A, Schols L et al (2001) The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich’s ataxia. J Mol Med 78(11):626–632PubMedCrossRef
13.
go back to reference Asaad NE-MA, Al Suwaidi J (2010) Recurrent ventricular tachycardia in patient with Friedreich’s ataxia in the absence of clinical myocardial disease. Pacing Clin Electrophysiol 33(1):109–112PubMedCrossRef Asaad NE-MA, Al Suwaidi J (2010) Recurrent ventricular tachycardia in patient with Friedreich’s ataxia in the absence of clinical myocardial disease. Pacing Clin Electrophysiol 33(1):109–112PubMedCrossRef
14.
go back to reference Groh W (2004). In: Zipes DP, Jalife J (eds) Arrhythmias in patients with neurologic disorders, in cardiac electrophysiology: from cell to bedside. WB Saunders, Philadelphia, pp 640–650 Groh W (2004). In: Zipes DP, Jalife J (eds) Arrhythmias in patients with neurologic disorders, in cardiac electrophysiology: from cell to bedside. WB Saunders, Philadelphia, pp 640–650
15.
go back to reference SP Giugliano GR (2007) Friedreich’s ataxia as a cause of premature coronary artery disease. Tex Heart Inst J 34(2):214–217 SP Giugliano GR (2007) Friedreich’s ataxia as a cause of premature coronary artery disease. Tex Heart Inst J 34(2):214–217
16.
go back to reference Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147PubMed Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147PubMed
17.
go back to reference Alboliras ET, Shub C, Gomez MR et al (1986) Spectrum of cardiac involvement in Friedreich’s ataxia: clinical, electrocardiographic and echocardiographic observations. Am J Cardiol 58(6):518–524PubMedCrossRef Alboliras ET, Shub C, Gomez MR et al (1986) Spectrum of cardiac involvement in Friedreich’s ataxia: clinical, electrocardiographic and echocardiographic observations. Am J Cardiol 58(6):518–524PubMedCrossRef
18.
19.
go back to reference Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42(9):1687–1713PubMedCrossRef Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42(9):1687–1713PubMedCrossRef
20.
go back to reference Jessup M, Abraham WT, Casey DE et al (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):1977–2016PubMedCrossRef Jessup M, Abraham WT, Casey DE et al (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):1977–2016PubMedCrossRef
21.
go back to reference CM Sedlak TL, Straatman L (2004) Cardiac transplantation: a temporary solution for Friedreich’s ataxia-induced dilated cardiomyopathy. J Heart Lung Transplant 23:1304–1306CrossRef CM Sedlak TL, Straatman L (2004) Cardiac transplantation: a temporary solution for Friedreich’s ataxia-induced dilated cardiomyopathy. J Heart Lung Transplant 23:1304–1306CrossRef
22.
go back to reference Segovia J A-PL, Burgos R, L. Silva, et al (2001) Heart transplantation in Friedreich’s ataxia and other neuromuscular diseases. J Heart Lung Transpl 20:169 Segovia J A-PL, Burgos R, L. Silva, et al (2001) Heart transplantation in Friedreich’s ataxia and other neuromuscular diseases. J Heart Lung Transpl 20:169
23.
go back to reference E-BA Yoda M, Arusoglu L, Tendrich G, Minami K, Korfer R (2006) Permanent use of a ventricle assist device for dilated cardiomyopathy in Friedreich’s ataxia. J Heart Lung Transplant 25:251–252CrossRef E-BA Yoda M, Arusoglu L, Tendrich G, Minami K, Korfer R (2006) Permanent use of a ventricle assist device for dilated cardiomyopathy in Friedreich’s ataxia. J Heart Lung Transplant 25:251–252CrossRef
24.
go back to reference Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the Surgeons. J Am Coll Cardiol 51(21):e1–e62PubMedCrossRef Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the Surgeons. J Am Coll Cardiol 51(21):e1–e62PubMedCrossRef
25.
go back to reference Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48(5):e247–e346PubMedCrossRef Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48(5):e247–e346PubMedCrossRef
26.
go back to reference Walker S, Levy T, Rex S, Paul VE (1999) Biventricular implantable cardioverter defibrillator use in a patient with heart failure and ventricular tachycardia secondary to Emery-Dreifuss syndrome. Europace 1(3):206–209PubMedCrossRef Walker S, Levy T, Rex S, Paul VE (1999) Biventricular implantable cardioverter defibrillator use in a patient with heart failure and ventricular tachycardia secondary to Emery-Dreifuss syndrome. Europace 1(3):206–209PubMedCrossRef
27.
go back to reference Luethje LG, Boennemann C, Goldfarb L, Goebel HH, Halle M (2004) Prophylactic implantable cardioverter defibrillator placement in a sporadic desmin related myopathy and cardiomyopathy. Pacing Clin Electrophysiol 27(4):559–560PubMedCrossRef Luethje LG, Boennemann C, Goldfarb L, Goebel HH, Halle M (2004) Prophylactic implantable cardioverter defibrillator placement in a sporadic desmin related myopathy and cardiomyopathy. Pacing Clin Electrophysiol 27(4):559–560PubMedCrossRef
Metadata
Title
Friedreich’s Ataxia: a review from a cardiology perspective
Authors
T. Bourke
D. Keane
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2011
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-011-0744-y

Other articles of this Issue 4/2011

Irish Journal of Medical Science (1971 -) 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.